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Introduction
Surgery is a major stressor that induces secretion of various 
substances such as prostaglandin, serotonin, and histamine 
as a reaction to localized tissue damage. In laparotomies with 
larger incisions, intra-abdominal surgical incision site pain 
is the most significant cause of acute postoperative pain. 
Extended lower midline laparotomies have relatively long inci-
sions, and thus effective pain control of the surgical incision 
site is particularly important. Pain at the intra-abdominal inci-
sion site which is not effectively controlled interferes with the 
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Objective
The goal of this study was to compare postoperative surgical site pain in gynecologic cancer patients who underwent 
elective extended lower midline laparotomy and managed their pain with either the ON-Q pain management system 
(surgical incision site pain relief system, ON-Q pump) or an intravenous patient-controlled analgesia pump (IV PCA). 
Methods 
Twenty gynecologic cancer patients who underwent elective extended lower midline laparotomy were divided into two 
groups. One group received a 72-hour continuous wound perfusion of the local anesthetic ropivacaine (0.5%, study group) into 
the supraperitoneal layer of the abdominal incision through the ON-Q pump. The other group received intravenous infusion 
pump of patient-controlled analgesia (fentanyl citrate 20 mg/mL · kg+ondansetron hydrochloride 16 mg/8 mL+normal saline). 
Postoperative pain was assessed immediately and at 6, 24, 48, 72, and 96 hours after surgery using the visual analogue scale.
Results
Postoperative surgical site pain scores at 24, 48, and 72 hours after surgery were lower in the ON-Q group than the 
IV PCA group. Pain scores at 24 hours and 48 hours after surgery were significantly different between the two groups 
(P = 0.023, P<0.001). Overall painkiller administration was higher in the ON-Q group but this difference was not 
statistically significant (5.1 vs. 4.3, P = 0.481).
Conclusion 
This study revealed that the ON-Q pain management system is a more effective approach than IV PCA for acute 
postoperative surgical site pain relief after extended lower midline laparotomy in gynecologic cancer patients.
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deep breathing necessary for early ambulation and recovery 
from atelectasis. Uncontrolled pain can also affect the respi-
ratory, cardiovascular, digestive, urinary and musculoskeletal 
system, thereby making it difficult to recover quickly from 
surgery, as well as affecting the overall success of the surgery. 
Various methods including epidural anesthesia, intraspinal an-
esthesia, intrapleural anesthesia, and intravenous patient con-
trolled analgesia are used to control postoperative pain, and 
parenteral narcotics are commonly used as anesthesia. Even 
though parenteral narcotics play a key role in the reduction 
of postoperative pain, they include many side effects such as 
nausea, vomiting, an itching sensation, palpitation, low blood 
pressure, weakening of muscles, and dizziness. Other serious 
side effects include difficult urinating, paralytic ileus, miosis, 
increased intracranial pressure and respiratory suppression. 
There have been many attempts to reduce these side effects, 
such as combining parenteral narcotics with other drugs or 
adjusting the dose of narcotic analgesia, but some side effects 
still persist.
Continuous injection of local analgesia into the surgical inci-
sion site has been effectively used to reduce the side effects 
of narcotics [1-16]. The ON-Q pain management system (ON-Q 
PainBuster, referred to as ON-Q pump) created by the I Flow 
Corp. (Lake Forest, CA, USA) is a device that continuously 
administers local analgesia directly into the intra-abdominal 
surgical wound site. Studies comparing the use of this device 
to a placebo have been carried out over the past several years 
in numerous surgical departments [4,17-19]. However, no 
study has evaluated postoperative surgical incision site pain 
control using the ON-Q pump in gynecologic cancer patients 
who underwent oncologic surgeries with an extended lower 
midline incision.
This study randomly selected gynecologic cancer patients 
who had undergone oncologic surgeries with an extended 
lower midline incision, and compared postoperative intra-
abdominal surgical incision site pain between a group that 
administered local analgesia directly into the incision site 
wound by ON-Q infusion pump, and a group that adminis-
tered parenteral narcotics via intravenous patient-controlled 
analgesia (referred to as IV PCA).
Materials and Methods 
Gynecology oncologic patients who completed baseline stud-
ies with a confirmed diagnosis of carcinoma between Novem-
ber 2011 and April 2012 at the Department of Obstetrics and 
Gynecology, Severance Hospital, Yonsei University College of 
Medicine, Seoul, Korea were selected as study subjects. Twen-
ty patients consented to use a pain control device following 
gynecology oncologic surgery and were randomly divided 
into two groups of ten. Postoperative intra-abdominal surgi-
cal incision site pain was compared between the group that 
administered local analgesia through an ON-Q pump (ON-Q 
pain management system, I Flow Corp.) inserted into the sur-
gical incision site, and the group that administered parenteral 
narcotics via IV PCA. The groups consisted of patients who 
underwent laparotomy through a lower midline incision that 
extended 6 to 7 cm above the umbilicus from the pubic bone. 
Surgeries were limited to the staging operation, including 
total abdominal hysterectomy (or radical abdominal hysterec-
tomy) and bilateral pelvic lymph node dissection, but could be 
modified by each diagnosis. Patients who received an Ameri-
can Society of Anesthesiologist grade of more than IV; had an 
allergic reaction to ropivacaine hydrochloride, fentanyl citrate 
or ketorolac tromethamine; had a history of drug or alcohol 
addiction in the last six months; or had serum creatinine levels 
greater than 2 mg/dL were excluded from this study. 
Fig. 1. Visual analogue scale (VAS): The VAS provides a simple and efficient measure of pain intensity that has been used widely and 
consists of a 10 cm horizontal line with the two endpoints labeled as “no pain” and “worst pain.” The distance (centimeters) between the 
low end of the VAS and the patient’s mark is used as a numerical index of pain intensity.
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A multifilament synthetic absorbable suture was used for 
closure from the peritoneum to the subcutaneous layer, and a 
disposable skin stapler with a width of 9.9 mm was used to 
suture the skin. All surgeries and insertion of the ON-Q pump 
catheter were performed by the same surgeon and surgical 
assistants using standard surgical procedures. 
Age, body mass index (BMI), duration of surgery, length of 
incision, duration of hospitalization following surgery, final 
diagnosis, old scar revisions, name of operation, postoperative 
surgical incision site pain score at each point, and the number 
of times postoperative analgesia was administered were all 
noted in electronic medical records. The visual analogue scale 
(VAS) was used to assess pain (Fig. 1). VAS provides a simple, 
minimally intrusive measure of pain intensity that has been 
widely utilized in research settings that require a quick and 
quantitative pain index. VAS consists of a 10-cm horizontal 
line with two endpoints labeled as “no pain” and “the worst 
possible pain.” The distance (in centimeters) from the low end 
point of VAS to the patient’s mark is considered a numerical 
index of pain intensity. The patients used the VAS to report a 
postoperative pain score at the intra-abdominal surgical inci-
sion site immediately following surgery, as well as 6, 24, 48, 
72, and 96 hours after surgery. During surgery, both groups 
received 20 µg/mL of remifentanil at an average rate of 10 
mL/hr. For the ON-Q group, 50 µg/mL of fentanyl citrate was 
intravenously injected once at the end of surgery. For the IV 
PCA administered group, no additional analgesia was pro-
vided at the end of the surgery. Both groups controlled ad-
ditional pain only with an intravenous injection of ketorolac 
tromethamine (30 mg/mL) at the patients’ request. When the 
patients started ingesting soft diet, oral nonsteroidal anti-
inflammatory drugs (NSAIDs) were given three times daily.
1. ON-Q pain management system 
The ON-Q pain management system includes an elastomeric 
pump filled with local analgesia solution (total volume of 300 
mL), which is a mixture of 400 mg of ropivacaine hydrochlo-
ride (Nacaine [Huons] 40 mg/20 mL) and 100 mL of 0.9% 
normal saline. This elastomeric pump is connected to a cath-
eter inserted into the intra-abdominal surgical incision site, 
and is designed to inject 300 mL of 0.5% ropivacaine solution 
through two strands of soaker catheter at the rate of 2 mL/hr 
each for 72 hours with consistent pressure (10 psi) (Fig. 2).
Soaker catheters were placed by inserting 20-gauge guid-
ing needles into the subfascial supraperitoneal layer of the 
surgical incision after having sutured up to the peritoneum. 
The guiding needles were placed about 3 cm from the midline 
incision at the upper and lower position of the incision line. 
Once the introducer was fixed in the desired location, the 
needle was removed and a length of catheter approximately 
6 to 10 cm was embedded in the incisional wound prior to 
suturing the skin. When both upper and lower catheters were 
fixed securely, a bolus of ropivacaine (10 mg/5 mL) was in-
jected through both strands of soaker catheters and the ON-Q 
infusion pump was connected immediately. The pump con-
tents were then continuously infused into the surgical incision 
site at a flow rate of 4 mL/hr (2 mL/hr per catheter) for 72 
hours. The catheters located in the subfascial supraperitoneal 
layer were so thin that no subcutaneous suture was neces-
sary, although fixed dressing of catheters was necessary at 
the injection site. An extra 20 mg/10 mL of ropivacaine was 
injected directly into the subcutaneous layer prior to suturing 
the skin (Fig. 3).
Fig. 2. Elastometric pump filled with local anesthetic. The protec-
tive cap is first removed from the pump, a syringe filled with local 
anesthetic is attached to the fill port, and the fluid is injected into 
the pump.
Fill port
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2. Intravenous patient-controlled analgesia 
Before surgery was completed, IV PCA was initiated via in-
travenous infusion (Accufuser Plus) with a total of 100 mL 
of mixed solution of fentanyl citrate (20 mg/mL per kg) and 
ondansetron hydrochloride (16 mg/8 mL) in 0.9% normal 
saline, which is the standard solution at the study institution. 
Although IV PCA was infused continuously at the basic flow 
rate of 2 mL/hr, 0.5 mL of bolus can be injected if the patients 
press the button once upon experiencing pain. The lock-out 
time for each bolus injection was 15 minutes. 
For statistical analysis, a descriptive analysis was carried out 
first. The Mann–Whitney U test was used to examine differ-
ences in continuous variables between the groups, and Fish-
er’s exact chi-square test was utilized to examine differences 
in nominal variables between groups. P-values less than 0.05 
was considered statistically significant. Statistical analyses 
were performed with PASW statistics ver. 18.0 for Windows 
(SPSS Inc., Chicago, IL, USA).
Results
Among the 20 patients that participated in this study, ten 
were in the ON-Q group and ten were in the IV PCA group. 
No patients stopped taking medication due to side effects 
or for other reasons, although two patients in the IV PCA 
administered group had to temporarily stop medication due 
to nausea and dizziness in the middle of administration on 
the day of surgery. In these cases, medication was resumed 
within several hours once the side effects were controlled by 
allopathic medication, and ultimately the complete dosage of 
IV PCA was dispensed.
Table 1 summarizes the basic characteristics of each anal-
gesia group including age, BMI, duration of surgery, length of 
incision, duration of hospitalization, final diagnosis, whether 
or not old scars were revised, and name of operation. The 
average age of the ON-Q and IV PCA groups were 56.2 ± 8.2 
years and 50.8 ± 8.2 years, respectively. The average length 
of incision for the ON-Q group was longer than that of the IV 
PCA group (25.3 ±1.2 cm vs. 24.7 ±1.1 cm). Differences in 
age and incision length were not statistically significant. There 
was also no statistically significant difference between the 
ON-Q group and the IV PCA group in terms of BMI, duration 
of surgery, duration of hospitalization, and whether or not old 
scar revision was performed. Two patients in the ON-Q group 
and three patients in the IV PCA group underwent surgery fol-
lowing a diagnosis of uterine cervical cancer, and two patients 
in the ON-Q group and three patients in the IV PCA group un-
derwent surgery following a diagnosis of endometrial cancer. 
One patient in the ON-Q group was diagnosed with recurrent 
Fig. 3. Placement of infusion cath-
eters. Inserting the Soaker catheters 
into the subfacial supraperitoneal 
layer (A). The introducer needle is 
placed approximately 3 cm from the 
midline incision (B).
A  B
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ovarian cancer and underwent a debulking operation includ-
ing total abdominal hysterectomy and lymphadenectomy at 
this study institution, followed by bilateral salpingo-oophorec-
tomy at other institution. There were no statistically significant 
differences between the groups in terms of final diagnosis 
and surgeries that were performed (Table 1).
The average postoperative pain score at the surgical incision 
site in the ON-Q group was lower than the IV PCA group im-
mediately after surgery, as well as 24, 48, and 72 hours after 
surgery (Table 2), although the differences were statistically 
significant only at 24 hours and 48 hours (24 hours, P=0.023; 
48 hours, P<0.001). This suggests that the intra-abdominal 
surgical incision site was less painful in the ON-Q group dur-
ing the postoperative acute phase. On the other hand, the 
average pain score 96 hours after surgery was significantly 
higher in the ON-Q group (2.9 ± 0.9) than the IV PCA group 
Table 1. Patient characteristics (n=20)
Characteristic ON-Q group (n=10) IV PCA group (n=10) P-value
Age (yr) 56.2 ± 8.2 50.8 ± 8.2 0.143
BMI (kg/m2) 25.4 ± 4.2 25.0 ± 5.7 0.393
Operation time (hr)   3.9 ± 1.0   3.3 ± 1.1 0.247
Length of incision (cm) 25.3 ± 1.2 24.7 ± 1.1 0.315
Postoperative hospital stay (day)   9.9 ± 3.7   9.2 ± 3.0 0.796
Diagnosis 0.479
Ovarian cancer        5 (50.0)        4 (40.0)
Cervix cancer        2 (20.0)        3 (30.0)
Endometrial cancer        3 (30.0)        3 (30.0)
Old scar revision 0.763
Yes        1 (10.0)        1 (10.0)
No        9 (90.0)        9 (90.0)
Operation name 0.590
Staging laparotomy (TAH, BSO, BPLD, PALD, Om, la)        4 (40.0)        4 (40.0)
Staging laparotomy (TAH, BSO, BPLD, PALD)        3 (30.0)        3 (30.0)
Radical hysterectomy (RAH, BSO, BPLD, PALD)        2 (20.0)        3 (30.0)
Debulking operation (TAH, BPLD, PALD, multiple biopsies)        1 (10.0)     0
Values are presented as mean±standard deviation or number (%).
IV PCA, intravenous patient-controlled analgesia; BMI, body mass index; TAH, total abdominal hysterectomy; BSO, bilateral salpingo-oo-
phorectomy; BPLD, bilateral pelvic lymph node dissection; PALD, paraaortic lymph node dissection; Om, total omentectomy; Ia, incidental 
appendectomy; RAH, radical abdominal hysterectomy. 
Table 2. Comparison On-Q group and intravenous patient-controlled analgesia (IV PCA) group
Variables ON-Q group (n=10) IV PCA group (n=10) P-value
Postoperative surgical site pain scores 
Immediate postoperative 6.3 (1.5) 6.5 (2.2) 0.912
6 hr 4.2 (1.2) 3.5 (1.8) 0.247
24 hr 2.6 (0.7) 3.9 (1.4) 0.023
48 hr 1.9 (0.6) 4.7 (1.6) <0.001
72 hr 2.5 (0.9) 3.1 (1.2) 0.353
96 hr 2.9 (0.9) 2.1 (0.6) 0.035
Number of painkiller administration 5.1 (3.4) 4.3 (3.3) 0.481
Values are presented as mean (standard deviation).
www.ogscience.org98
Vol. 56, No. 2, 2013
(2.1± 0.6) (P=0.035) (Fig. 4). The number of times painkiller 
administered additional postoperative analgesia was higher 
in the ON-Q group (5.1± 3.4) than that in the IV PCA group 
(4.3 ± 3.3), although this difference was not statistically sig-
nificant (P=0.481). 
Discussion 
Local analgesia is a relatively safe and inexpensive painkiller 
that controls pain by blocking the transmission of pain from 
peripheral nerves at the damaged site. However, the use of 
local analgesia is limited and frequent re-administration is 
necessary due to the relatively short analgesic effect, which 
is 2 to 6 hours on average for single dose. The ON-Q pump 
created by I Flow resolves the issue of repetitive administra-
tion and efficiently blocks the transmission of pain from the 
surgical incision site to the spinal cord via a continuous infu-
sion system [20-25]. Wound perfusion with local anesthetic 
solution by an indwelling irrigation unit was first designed 
by Capelle [26] in the 1930’s. In the 1950’s, Blades and Ford 
[27] refined this technique for thoracotomy incisions with the 
insertion of a fine catheter before closure, and noticed an as-
sociated decrease in opioid requirements. Additional research 
on upper abdominal wounds confirmed a decrease in opioid 
requirements. Nevertheless, this technique did not achieve 
popularity at that time. It did, however, begin to receive at-
tention as a ‘new method of pain relief’ when re-discovered 
by Samarji [28] in 1972 [29,30]. The ON-Q pump, which pro-
vides a continuous infusion of local analgesia into the surgical 
incision, has proven to be an effective method of managing 
postoperative pain and reducing the use of opioids in a wide 
range of medical fields including general surgery, urology, and 
thoracic surgery [31-39]. Fredman et al. [17] and Givens et al. 
[18] evaluated the effect of the ON-Q pump on pain reduction 
and opioid use in obstetric patients after caesarian section. 
They demonstrated the importance of maintaining blood lev-
els of unbound ropivacaine below the toxic threshold by com-
paring a group using local anesthetics with a placebo group 
using normal saline. Gupta et al. [19] showed that application 
of the ON-Q pump provides more effective postoperative pain 
relief for total abdominal hysterectomy than a placebo, while 
Zimberg et al. [40] revealed that the ON-Q pump can reduce 
the duration of hospitalization following total abdominal hys-
terectomy, thereby cutting hospital costs up to 30%.
IV PCA is the most commonly used method in postoperative 
pain control for patients undergoing gynecology oncologic 
surgery with an extended midline incision. However, this study 
found that the ON-Q pump was more helpful in pain control 
at the surgical incision site during the postoperative acute 
phase, and was significantly more effective at 24 hours and 
48 hours after surgery (P=0.023, P<0.001, respectively). Pain 
scores at the surgical incision site decreased as time passed 
after surgery in both the ON-Q group and the IV PCA group, 
whereas the pain score increased at 96 hours after surgery in 
both groups. This finding at 96 hours after surgery suggests 
less meaningful because both ON-Q and IV PCA had already 
been dispensed at this point. In terms of the number of times 
a patient administered additional analgesia, on average the 
ON-Q group administered analgesia more frequently than 
the IV PCA group (5.1± 3.4 vs. 4.3 ± 3.3, respectively). The 
autonomic nerve system including the inferior hypogastric 
nerve plexus can be damaged by a wide transection of the 
uterosacral ligament, particularly in radical abdominal hyster-
ectomy, and is known as one of the main factors in immediate 
postoperative pain [41,42]. This study only considered postop-
erative pain at the surgical incision site and excluded visceral 
pain such as the pain described above, or musculoskeletal 
pain due to the long operating time. Considering the differ-
ence in the number of times of analgesic was administered 
between the two groups was less than 1.0, pain score errors 
associated with the relief of visceral or musculoskeletal pain 
should be negligibly small. The average period of hospitaliza-
tion was longer in the ON-Q group (9.9 ± 3.7 days) than in 
the IV PCA group (9.2 ± 3.0 days) (P=0.796), but the median 
Fig. 4. Mean change in postoperative surgical site pain. VAS, vi-
sual analogue scale; post op, postoperative; IV PCA, intravenous 
patient-controlled analgesia.
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value for duration of hospitalization in the ON-Q group was 
8.0 days, which was shorter than the 8.5 days for the IV PCA 
group. The average duration of hospitalization in the ON-Q 
group seems to be skewed by one patient in the ON-Q group 
who was discharged on the day 19 after finishing the first 
postoperative adjuvant chemotherapy on day 14 following 
the staging operation. While two patients in the IV PCA group 
temporarily stopped administration of IV PCA due to nausea 
and dizziness, the ON-Q group did not have any side effects 
or any cessation during administration. Thus the ON-Q pump 
was able to substantially reduce the need for additional drugs 
such as anti-emetics. 
This study differs from previous ON-Q pump studies in that 
it compares the effect of the ON-Q pump with IV PCA instead 
of a placebo. IV PCA is generally administered in gynecology 
oncologic laparotomies and has limited use during the post-
operative acute phase due to various side effects of narcotics. 
However, if there are minimal side effects, IV PCA can be used 
in accordance with additional medication such as antiemetics. 
Hypersensitivity is a known side effect of the ON-Q pump 
and is caused by the ester series of anesthetics, but it is very 
rare and occurs in less than 1% of patients using the ON-Q 
pump [43]. Because ON-Q pump catheters are embedded in 
the incisional wound during the operation, it is possible to re-
duce unnecessary medication without generalized side effects 
or additional pain. Moreover, by relieving pain in the surgical 
wound area, which is the main cause of postoperative pain 
in the acute phase, the ON-Q pump helps prevent pulmonary 
complications such as atelectasis and aids in early ambula-
tion and early recovery of bowel movements in gynecology 
oncologic surgeries with a long incision, all without the use of 
IV PCA. Consequently, the ON-Q pump is highly beneficial to 
cancer patients who desire a quick recovery from surgery for 
postoperative adjuvant anti-cancer therapy.
This study shows that acute postoperative surgical incision 
site pain is well controlled using only the ON-Q pump and 
additional intravenous NSAIDs, without opioid-based IV PCA, 
after laparotomy of gynecologic cancer with an extended 
lower midline incision. However, this study had a small sample 
size which made it difficult to use a linear regression model to 
determine whether the use of additional pain relievers or the 
average period of hospitalization was affected by parameters 
other than the method of postoperative pain control. There-
fore, future studies should use a larger sample size and should 
evaluate the effect of the ON-Q pump on generalized pain 
such as visceral and musculoskeletal pain. In addition, future 
studies should specify indices of early recovery and establish a 
multi-regimen protocol for postoperative pain control.
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